{"database": "lobbying", "table": "lobbying_activities", "rows": [[1991011, "b858465c-6fff-4f4d-81a9-74c1f1837dc3", "Q2", "CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.", 8511, "HEREDITARY HEMORRHAGIC TELANGIECTASIA FOUNDATION", 2017, "second_quarter", "MED", "Research opportunities at the Department of Defense and the Centers for Disease Control.\nFY 2017, Labor-HHS Appropriations Act, blood and bleeding disorders.\nFY 2017, Defense Appropriations Act, defense health programs.\nHR 1628, American Health Care Act, Medicaid and Essential Health Benefits\nHR 244, FY 17 Consolidated Appropriations Act, defense medical research and CDC funding for HHT surveillance\nHR 3219, FY 18 Defense Appropriations Act, defense medical research", "HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE", 10000, null, 0, 0, "2017-07-18T10:58:20.573000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1991011"], "units": {}, "query_ms": 7.516087964177132, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}